Paradoxical and persistent renal impairment in Henoch-Schönlein purpura after high-dose immunoglobulin therapy.
Blanco
R
R
González-Gay
M A
MA
Ibáñez
D
D
Sánchez-Andrade
A
A
González-Vela
C
C
D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use; D018450:Disease Progression; D005922:Glomerulonephritis, IGA / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D011695:IgA Vasculitis / Q000150:complications / Q000503:physiopathology* / Q000628:therapy*; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D007677:Kidney Function Tests; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D011507:Proteinuria
D016756:Immunoglobulins, Intravenous; D003520:Cyclophosphamide; D008775:Methylprednisolone